Pharmazon has received a minority investment from a private investor
The shareholders of Pharmazon have sold the company to a private investor.
Pharmazon is a B2B distributor of OTC and parapharmacy products to French pharmacies. Its core business is to buy products directly from laboratories, negotiating good conditions and selling them online through a modern website which looks similar to Amazon.com.
The company's shareholders are the CEO and General Director.
Oaklins' team in France advised the seller in this transaction.
Talk to the deal team
Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.Learn more
Renita Medical raises seed funding
Renita Medical Oy, a health tech company, has received seed funding which provides it with resources to finalize development and bring it to commercial launch.Learn more
Bionix has been recapitalized by Argosy Private Equity
Bionix, LLC has been recapitalized by Argosy Private Equity.Learn more